Goldman Sachs Starts Tango Therapeutics Inc. (TNGX) at Buy
Tweet
Share
E-mailGet Alerts TNGX Hot Sheet
Price: $25.60 -0.19%
Rating Summary:
13 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
13 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Goldman Sachs analyst Chris Shibutani initiates coverage on Tango Therapeutics Inc. (NASDAQ: TNGX) with a Buy rating and a price target of $17.00.
For an analyst ratings summary and ratings history on Tango Therapeutics Inc. click here. For more ratings news on Tango Therapeutics Inc. click here.
Shares of Tango Therapeutics Inc. closed at $12.93 yesterday.
You May Also Be Interested In
- Tango Therapeutics Inc. (TNGX) PT Raised to $35 at Guggenheim
- Evercore ISI Starts Alvotech SA (ALVO) at Outperform
- BMO Capital Resumes Snowline Gold Corp (SGD:CN) (SNWGF) at Outperform
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
